PR Newswire Asia's news > Biotechnology

 < Previous page   |   Title only   |   Print 
     
Angel Yeast Showcases Yeast-Based Innovations for Animal Nutrition at TUYEM 2026
SHANGHAI , June 8, 2026 /PRNewswire/ -- Angel Yeast (SH600298), one of the world's leading yeast manufacturers, recently presented its latest research and product developments at the 16th International ...
2026-06-08T    Agriculture   Biotechnology   Food/Beverages   Health Care/Hospital 
WuXi Biologics Ireland Wins Top Honors at the 2026 Life Sciences Industry Awards
DUNDALK, Ireland , June 8, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that its Ireland site ...
2026-06-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Dayspring Pharma Announces Positive Topline Results from Phase II Clinical Trial of CG2001 for the Treatment of Androgenetic Alopecia (AGA)
SEOUL, South Korea , June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of ...
2026-06-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program
SAN DIEGO , June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection) and the appointment of Global ...
2026-06-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
OriCell's GPC3 CAR-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma
SHANGHAI , June 8, 2026 /PRNewswire/ -- OriCell Therapeutics Holdings Limited ( The "Company" or "Oricell") , annou nced that its proprietary GPC3-targeted autologous CAR-T therapy, ...
2026-06-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Antengene Presented First Preclinical Data at EULAR 2026 Showing ATG-207 Promotes Regulatory T Cell Induction and Immune Tolerance
SHANGHAI and HONG KONG , June 8, 2026 /PRNewswire/ -- Antengene Corporation Limited  ( "Antengene" , SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated ...
2026-06-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than Semaglutide
NEW ORLEANS , June 8, 2026 /PRNewswire/ -- Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences"), a commercial-stage biopharmaceutical company focused on discovering and developing ...
2026-06-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page 

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved